Case Western Reserve, ICBM Medical Sign Agreement to Commercialize Biosensor Technology

Case Western Reserve and ICBM Medical sign an agreement to commercially advance a low-cost, rapid catalytic biomarker technology that improves patient screening and monitoring for a range of clinical conditions.

Read More  >